Core Viewpoint - The announcement indicates that the wholly-owned subsidiary of Pian Zai Huang Investment plans to invest 200 million RMB as a limited partner in the Gao Xin Run Xin Fund, which targets a total fundraising scale of 1 billion RMB, representing 20% of the fund's goal [1] Group 1: Investment Details - The Gao Xin Run Xin Fund primarily focuses on the healthcare sector, including pharmaceuticals, medical devices, upstream supply chains, health food products, synthetic biology, chemical materials, and consumer healthcare [1] - Investments outside the healthcare sector will not exceed 10% of the total committed capital of the fund [1] Group 2: Transaction Classification - This investment constitutes a related party transaction but does not qualify as a major asset restructuring as defined by the "Measures for the Administration of Major Asset Restructuring of Listed Companies" [1]
片仔癀:全资子公司片仔癀投资拟认缴出资2亿元参与高鑫润信基金